Clinical Trial Update: Safety and Effectiveness Study of SQ-Kyrin TMVr System for Degenerated Mitral Regurgitation [NA]

View source ↗

Summary

This clinical trial update describes a safety and effectiveness study of the SQ-Kyrin TMVr System for degenerative mitral regurgitation and indicates enrollment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Mitral Regurgitation

Drugs mentioned

• SQ-Kyrin TMVr System

Snippet

Sponsor: Shanghai Shenqi Medical Technology Co., Ltd | Conditions: Degenerated Mitral Regurgitation | NA | Status: ENROLLING_BY_INVITATION